hit counter
  • PREMIUM
  • Frontpage
  • Top Stories
  • Business
  • Fintech
  • VALUE INVESTING
  • Timeless Reading
  • InvestorsHub-NewsWire
    • Loading
Search
Wednesday, August 10, 2022
  • PREMIUM
  • Frontpage
  • Top Stories
  • Business
  • Fintech
  • VALUE INVESTING
  • Timeless Reading
  • InvestorsHub-NewsWire
    • Loading
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
ValueWalk ValueWalk ValueWalk
  • PREMIUM
  • Frontpage
  • Top Stories
  • Business
  • Fintech
  • VALUE INVESTING
  • Timeless Reading
  • InvestorsHub-NewsWire
    • Loading
Home Business Valeant Raises Cash Portion of Allergan Offer As Stock Price Sinks
  • Business

Valeant Raises Cash Portion of Allergan Offer As Stock Price Sinks

Mark Melin
-
May 28, 2014, 10:29 am
0
Valeant Raises Cash Portion of Allergan Offer As Stock Price Sinks

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) raised the stakes in its hostile bid for Allergan, Inc. (NYSE:AGN), to $58.30 per share, bringing the total bid to $166.16 per share while at the same time executing a separate deal with Nestle to shed some of Valeant’s skin care products and raise cash.